Manufacturer-sponsored drug coupon use and drug-switching behavior among patients with type 2 diabetes

Patients who started their treatment with generic metformin had the lowest rate of drug switching. Using coupons to initiate brand-name drugs in classes with prevalent coupons was associated with reduced medication switching to other class drugs.

Authors

Institutions

Publication Details

Journal
Journal of Managed Care & Specialty Pharmacy
Published
2024-08-30
DOI
https://doi.org/10.18553/jmcp.2024.30.9.903
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Manufacturer-sponsored drug coupon use and drug-switching behavior among patients with type 2 diabetes

Mariana P. Socal, Stacie B. Dusetzina, Soyeon Kang, Yang Wang
Journal of Managed Care & Specialty Pharmacy
Pharmaceutical Economics and Policy
article

Manufacturer-sponsored drug coupon use and drug-switching behavior among patients with type 2 diabetes

Mariana P. Socal, Stacie B. Dusetzina, Soyeon Kang, Yang Wang
article en

Abstract

Patients who started their treatment with generic metformin had the lowest rate of drug switching. Using coupons to initiate brand-name drugs in classes with prevalent coupons was associated with reduced medication switching to other class drugs.

Journal of Managed Care & Specialty PharmacyVol. 30(9)
Johns Hopkins University (US), Vanderbilt University (US)
Good health and well-being
Openalex Percentile: Top 82%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.